| Q35788728 | A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease |
| Q39581510 | A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle. |
| Q43662412 | A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis |
| Q39880831 | Activation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA. |
| Q37691656 | Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA |
| Q40048036 | Activation of the Epstein-Barr virus replicative cycle by human herpesvirus 6. |
| Q36872412 | Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma |
| Q36255516 | An oriP expression vector containing the HIV-1 Tat/TAR transactivation axis produces high levels of protein expression in mammalian cells |
| Q35739297 | Autoantigenic proteins that bind recombinogenic sequences in Epstein-Barr virus and cellular DNA |
| Q33851925 | Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites |
| Q33930251 | BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro |
| Q36919438 | Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection |
| Q33880983 | Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter |
| Q39873652 | Comparing transcriptional activation and autostimulation by ZEBRA and ZEBRA/c-Fos chimeras |
| Q36904325 | Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication |
| Q36799631 | Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia |
| Q24679432 | EBNA2 and Activated Notch Induce Expression of BATF |
| Q35140295 | Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus |
| Q38597250 | Epstein-Barr Virus-Specific Humoral Immune Responses in Health and Disease |
| Q36700868 | Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants |
| Q33832940 | Epstein-Barr virus WZhet DNA can induce lytic replication in epithelial cells in vitro, although WZhet is not detectable in many human tissues in vivo |
| Q36919210 | Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells |
| Q39494552 | Epstein-Barr virus infection and immunoregulation in man. |
| Q36464527 | Epstein-Barr virus infection at mucosal surfaces: detection of genomic variants with altered pathogenic potential |
| Q36810617 | Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. |
| Q36914351 | Epstein-Barr virus with heterogeneous DNA disrupts latency |
| Q42664262 | Epstein-barr virus (P3HR-1) defective DNA codes for components of both the early antigen and viral capsid antigen complexes |
| Q36792014 | Expression of the BZLF1 latency-disrupting gene differs in standard and defective Epstein-Barr viruses |
| Q43679392 | Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes |
| Q33688737 | Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency |
| Q40141491 | Growth of B95-8 cells and expression of Epstein-Barr virus lytic phase in serum-free medium. |
| Q92295697 | How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis |
| Q37554196 | Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1. |
| Q45807268 | Identification of Epstein-Barr virus genes expressed during the early phase of virus replication and during lymphocyte immortalization |
| Q36802259 | Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1 |
| Q35881166 | Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. |
| Q35829364 | Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. |
| Q34160976 | Immortalization of human primary B lymphocytes in vitro with DNA |
| Q36791391 | Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus |
| Q35898898 | Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis. |
| Q36901311 | Latent and viral replicative transcription in vivo from the BamHI K fragment of Epstein-Barr virus DNA. |
| Q34532370 | Latent membrane protein 1 inhibits Epstein-Barr virus lytic cycle induction and progress via different mechanisms. |
| Q36651807 | Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2. |
| Q36855762 | Mapping of genes in BamHI fragment M of Epstein-Barr virus DNA that may determine the fate of viral infection. |
| Q37164004 | Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses |
| Q36640447 | Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation |
| Q36900189 | P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread |
| Q36862582 | Palindromic structure and polypeptide expression of 36 kilobase pairs of heterogeneous Epstein-Barr virus (P3HR-1) DNA. |
| Q36974652 | Points of recombination in Epstein-Barr virus (EBV) strain P3HR-1-derived heterogeneous DNA as indexes to EBV DNA recombinogenic events in vivo |
| Q37273424 | Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus |
| Q36883713 | Promiscuous trans activation of gene expression by an Epstein-Barr virus-encoded early nuclear protein |
| Q34363413 | Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle |
| Q39596888 | Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. |
| Q36690443 | Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection |
| Q35874857 | Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. |
| Q39605212 | Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells |
| Q36887535 | Sequences of the Epstein-Barr Virus (EBV) large internal repeat form the center of a 16-kilobase-pair palindrome of EBV (P3HR-1) heterogeneous DNA. |
| Q37252690 | Signal transducer and activator of transcription 3 limits Epstein-Barr virus lytic activation in B lymphocytes. |
| Q40128299 | Strain-specific transcription and translation of the BamHI Z area of Epstein-Barr Virus. |
| Q40133709 | Structure of defective DNA molecules in Epstein-Barr virus preparations from P3HR-1 cells |
| Q45266258 | Targeted gene disruption in Epstein-Barr virus |
| Q38333495 | The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes |
| Q39216150 | The Epstein-Barr virus proteins |
| Q39321358 | The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells |
| Q40782239 | The cytoplasmic amino-terminus of the Latent Membrane Protein-1 of Epstein-Barr Virus: relationship between transmembrane orientation and effector functions of the carboxy-terminus and transmembrane domain |
| Q36806641 | The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization |
| Q39753081 | The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules |
| Q40985245 | The position of the ZEBRA activation domain does not influence its biological activity |
| Q36829427 | The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. |
| Q38286548 | The switch between EBV latency and replication |
| Q34601537 | Transfection of a rearranged viral DNA fragment, WZhet, stably converts latent Epstein-Barr viral infection to productive infection in lymphoid cells. |
| Q39876966 | Two 21-kilodalton components of the Epstein-Barr virus capsid antigen complex and their relationship to ZEBRA-associated protein p21 (ZAP21). |
| Q37691053 | Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding |
| Q36889039 | Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells |
| Q39736781 | Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: lack of correlation between Met129 status and EBV strain identity |
| Q36775172 | Viral proteins associated with the Epstein-Barr virus transactivator, ZEBRA |